Quick Links
Past Events

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Supporters

This activity is supported by educational grants from Celgene Corporation, Genentech, Lilly USA, LLC, and Novartis Pharmaceuticals Corporation.
Privacy Policy
Terms & Conditions
Executive Board
Faculty Portal
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

8th Annual New York Lung Cancer Symposium®

8th Annual New York Lung Cancer Symposium®


Saturday, November 9, 2013
7:00 am Registration and Breakfast  
8:00 am Welcome, Introductions, and Pre-Session Survey  
Molecular Targeted Agents in NSCLC Moderators: Abraham Chachoua, MD and Harry Raftopoulos, MD
8:15 am Overcoming Resistance to EGFR TKIs Balazs Halmos, MD
8:35 am ALK Inhibitors: State of the Art Alice T. Shaw, MD, PhD
8:55 am Molecular Targeted Agents for Stage III NSCLC Bilal Piperdi, MD
9:15 am Question and Answer Session  
9:35 am BREAK  
SCLC and Supportive Care Moderators: Jorge E. Gomez, MD and Benjamin P. Levy, MD 
10:00 am New Horizons for Small-cell Lung Cancers Charles M. Rudin, MD, PhD
10:20 am New Treatments for Squamous Cell Lung Cancer Roman Perez-Soler, MD
10:40 am Current Approaches to Supportive Care Richard J. Gralla, MD
11:00 am Question and Answer Session  
11:10 am Post-Session Survey  
11:15 am Challenging Cases Panelists: Abraham Chachoua, MD, Jorge E. Gomez, MD, Harry D. Harper, MD and Bryan J. Schneider, MD
11:55 am LUNCH  
Best Practices in 2013: Part I Moderators: Richard J. Gralla, MD and Steven E. Vogl, MD
1:10 pm Pre-Session Survey  
1:15 pm Adjuvant Therapy Mark G. Kris, MD
  Debate: Is Bevacizumab-Based Therapy the SOC in Frontline Stage IV Nonsquamous NSCLC?  
1:35 pm PRO Bryan J. Schneider, MD
1:50 pm CON Benjamin P. Levy, MD
2:05 pm How I Approach Maintenance Therapy Mark G. Kris, MD
2:25 pm Question and Answer Session  
2:45 pm BREAK  
Best Practices in 2013: Part II Moderators: Bilal Piperdi, MD and Harry Raftopoulos, MD
  Debate: Is there an optimal TKI in EGFR-mutant Lung Cancers?  
3:05 pm PRO Gregory J. Riely, MD, PhD
3:20 pm CON Natasha B Leighl, BSc, MD, MSc
3:35 pm PD-(L)1 Inhibition: What Does the Future Hold? Naiyer A. Rizvi, MD
3:55 pm Post-Session Survey  
4:05 pm Question and Answer Session  
4:25 pm Closing Remarks  
4:30 pm Adjourn  

Become a Member

Forgot Password?
Filter By